Measured Wealth Private Client Group LLC Lowers Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Measured Wealth Private Client Group LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 12.5% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 2,194 shares of the healthcare conglomerate’s stock after selling 313 shares during the period. Measured Wealth Private Client Group LLC’s holdings in UnitedHealth Group were worth $1,283,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of UNH. WFA Asset Management Corp boosted its position in shares of UnitedHealth Group by 44.0% during the first quarter. WFA Asset Management Corp now owns 265 shares of the healthcare conglomerate’s stock worth $131,000 after buying an additional 81 shares during the period. First Trust Direct Indexing L.P. boosted its holdings in UnitedHealth Group by 0.4% in the first quarter. First Trust Direct Indexing L.P. now owns 13,820 shares of the healthcare conglomerate’s stock valued at $6,837,000 after purchasing an additional 54 shares during the period. RBA Wealth Management LLC boosted its holdings in UnitedHealth Group by 0.9% in the first quarter. RBA Wealth Management LLC now owns 11,785 shares of the healthcare conglomerate’s stock valued at $5,830,000 after purchasing an additional 109 shares during the period. Core Wealth Partners LLC boosted its holdings in UnitedHealth Group by 4.0% in the first quarter. Core Wealth Partners LLC now owns 1,044 shares of the healthcare conglomerate’s stock valued at $516,000 after purchasing an additional 40 shares during the period. Finally, Tempus Wealth Planning LLC boosted its holdings in UnitedHealth Group by 47.8% in the first quarter. Tempus Wealth Planning LLC now owns 652 shares of the healthcare conglomerate’s stock valued at $322,000 after purchasing an additional 211 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of recent research reports. Stephens decreased their target price on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. KeyCorp assumed coverage on UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 price target on the stock. Barclays cut their target price on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. Bank of America cut their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Finally, Truist Financial reiterated a “buy” rating and set a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Trading Up 0.1 %

Shares of UNH opened at $562.96 on Thursday. The stock has a fifty day moving average of $582.60 and a two-hundred day moving average of $540.48. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91. The company has a market capitalization of $519.85 billion, a PE ratio of 36.72, a price-to-earnings-growth ratio of 1.66 and a beta of 0.58. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $608.63.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s revenue was up 9.2% on a year-over-year basis. During the same period in the previous year, the firm posted $6.56 EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.49%. UnitedHealth Group’s payout ratio is 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.